-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability-quiz.ppt
May 29, 2025 - Evidence Table
Review the evidence table above. … unclear how the benefits and harms would compare in a smaller community hospital
Evidence Table … Review the evidence table above. … identified a priori as most likely to impact applicability are extracted for each study and entered in the table … identified a priori as most likely to impact applicability are extracted for each study and entered in the table
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability-quiz.ppt
May 29, 2025 - Evidence Table
Review the evidence table above. … unclear how the benefits and harms would compare in a smaller community hospital
Evidence Table … Review the evidence table above. … identified a priori as most likely to impact applicability are extracted for each study and entered in the table … identified a priori as most likely to impact applicability are extracted for each study and entered in the table
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
May 29, 2025 - TCA_PCT
Table F-2a. … Short NR NR 3 102 NR NR NR NR NR NR NR NR 52 102 103 Sweating 21 102 103 31 102 103 NR NR NR
PGB_PCT
Table … 11 164 9 164 NR NR NR NR NR NR NR NR NR NR NR Somnolence 13 164 164 30 164 164 NR NR NR
PGB_TCA
Table … day 12 Short NR NR NR NR NR NR NR NR NR NR NR NR 1 31 34 NR NR NR NR NR NR NR NR NR NR
PGB_H-2-H
Table … 14 Short 9 172 1 172 7 172 172 7 172 172 3 172 172 10 172 172 Depression 0 172 172
Lidocaine_PCT
Table
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-g.xlsx
May 29, 2025 - Risk of Bias Assessments
Table G-1
Table G-1. … Yes Yes No Unclear Yes Yes No Yes Yes Fair
Wilkinson, 2015b Yes No No No Yes Yes Yes Yes Yes Fair
Table … G-2
Table G-2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - Protocol .........................................................................................21
Tables … publications is customized (for example, using RSS feeds) to send daily email
updates and electronic tables … The five
tables below (Table 2, Table 3, Table 4, Table 5, and Table 6) outline the questions we consider … This report is organized by priority
area and consists of 15 tables—one for each priority area—in each … Ongoing Trials and Evidence Development (Two tables are provided: 1 for ongoing trials and 1 for
recently
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - Protocol .........................................................................................21
Tables … publications is customized (for example, using RSS feeds) to send daily email
updates and electronic tables … The five
tables below (Table 2, Table 3, Table 4, Table 5, and Table 6) outline the questions we consider … This report is organized by priority
area and consists of 15 tables—one for each priority area—in each … Ongoing Trials and Evidence Development (Two tables are provided: 1 for ongoing trials and 1 for
recently
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antibiotics-respiratory-infection_clinician.pdf
March 01, 2016 - See Table A in the Appendix
for further explanations and examples of these interventions. … and rates of continuing symptoms,
hospitalization, treatment failure, or mortality (���)
(Appendix Table … the rate of diarrhea and multidrug
resistance for streptococcal pneumonia strains (���)
(Appendix Table … ���), without affecting health care
utilization (���) or the risk of complications (���)
(Appendix Table … affecting acute otitis media complications (���) or parent
or patient satisfaction (���) (Appendix Table
-
effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
October 01, 2011 - ES key question tables: table 1c- added “e.g.;
“Ritalin” example 1c; 2a “i.e.: Atomoxetine”, 3c
added … Arranged order in tables to alphabetical (some
under drug subgroups) e.e.: Table 7
Peer Reviewer … See Tables 1 and 2, and information repeated
in Table 21 and 22
Peer Reviewer
#7
Results p 91 L … Tables revamped in section 3; table 15 US data
now; table 16 international; JZ’s suggestions
from ref … Adding references to the table would be most helpful as the
summary tables are important and may be
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
November 01, 2024 - ............................................................................................ 40
Tables … Critical Critically low
2.3 Data Extraction
Systematic reviews (SRs): Data were extracted into tables … Primary studies: Data were extracted into tables for the following fields: first author, year, study … Data tables were generated for articles
which were relevant evidence for each key question. … More details for SRs and primary studies are in Tables 3.2 and 3.4.
3.2.1 Results, Key Question 3
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-251-integrated-pain-management-app-F.xlsx
January 01, 2020 - Risk of Bias Assessments
Table F-1. IPMP RCTs
Table F-1. … No No Yes 2, 6, 12 months: Yes
24 months: Overall No, Differential Yes Yes Yes Fair
Table … Risk of bias assessments for randomized controlled trials of integrated pain management programs
Table … CPMP RCTs
Table F-2. … WL No Yes Poor
Table G-2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
November 07, 2023 - Decisions about tables to include in the
report itself vs. information to present in appendices is well … - Otherwise, tables and description are adequate and descriptive
Thank you. … Also, double check that the 2 is
superscripted in all of the tables/columns. … Public Comment
#3 (APA)
Results P 45 Earlier tables did not have heterogeneity in the header. … Public Comment
#3 (APA)
Results Table 27 This layout is different than tables above.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/clinical-care-rapid-review-appendix-c.xlsx
January 01, 2018 - List of Evidence Tables
Category Evidence Table
Characteristics Evidence Table C-1. … Evidence Table C-1
Evidence Table C-1. … C-2
Evidence Table C-2. … Evidence Table C-8
Evidence Table C-8. … Evidence Table C-22
Evidence Table C-22.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
May 29, 2025 - NPP_Pain
Table F-1a. … NR NR NR NR NR NR NR 130 131 Difference in LS means -0.11 95% CI NR -0.5 0.3 0.627
NPP_Response
Table … Fair NPP (DPN/PHN) PGB/GBP Pregabalin IR ≥50% improvement on DPRS 12 Short 59 131 176
NPP_Function
Table … NR NR NR NR 172 3.73 NR NR NR NR 167 172 Treatment difference -0.56 NR NR NR NR 0.733
NPP_Anxiety
Table … NR NR NR NR NR NR NR 130 131 Difference in LS means 0.28 95% CI NR -0.44 1 0.446
NPP_Depression
Table
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
September 01, 2011 - The tables below include the responses by the authors of the review to each comment that
was submitted … I would consider adding internal hyperlinks so that figures, tables,
citations, and internal crossreferences … Figures, tables and appendices are adequate and descriptive. … Jeni
Bastean
Tables Table 20. … None needed
Rebecca
Swift
Tables Liked the table in Introduction which mapped the drugs and their
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_clinician.pdf
September 01, 2016 - in relieving
symptoms as first-step treatments for adult outpatients
with mild to severe MDD (see Table … However,
the difference is not statistically different (see Table 2).
�� The evidence is too limited … SGA, versus switching to CBT, has similar beneficial
effects on response and remission rates (see Table … Please see below Table 3 for the abbreviation key. … Overview of Clinical Research Evidence (Continued)
Table 4: Common Adverse Effects Reported in Studies
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2023.pdf
January 01, 2023 - reduction of evidence gaps and improving
Learn more below:
✓ Click icons within each goal to access tables … journal/aim/best-of-2022
https://www.acpjournals.org/journal/aim/best-of-2022
8
List of Appendixes and Tables … New Research
Table C1. … Partnerships
Table D1. … Methods-Related Research
Table E1.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
January 08, 2013 - Table 1: Summary Table ............................................................................ … Thus, no update of the CER is warranted at this
time.
5
Table 1: Summary Table
Conclusions From … The Sn was 5
percent, and Sp was 98 percent (Table A). … Appendices
Appendix A: Search Methodology
Appendix B: Evidence Tables
Appendix C: Questionnaire … Do Not Know
percent (Table A).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
May 29, 2025 - NPP_Pain
Table F-1a. … NR NR NR NR 82 -2.8 NR NR NR NR 79 82 Mean difference in change 0.9 NR NR NR NR NR
NPP_Response
Table … Fair NPP (DPN/PHN) PGB/GBP Pregabalin IR ≥50% improvement on DPRS 12 Short 59 131 176
NPP_Function
Table … NR NR NR NR 172 3.73 NR NR NR NR 167 172 Treatment difference -0.56 NR NR NR NR 0.733
NPP_Anxiety
Table … NR NR NR NR NR NR NR 130 131 Difference in LS means 0.28 95% CI NR -0.44 1 0.446
NPP_Depression
Table
-
effectivehealthcare.ahrq.gov/sites/default/files/clinical-pathway-methods-report-appendix-k.pdf
February 01, 2018 - Guideline Evidence and Recommendation Rating Schemes ................................. 24
Tables … Table K-1. … Table K-1. … Search terms and strategies for each resource appear in tables K-2 through K-
8 below. … Table K-2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
January 01, 2014 - This is done in the tables (I,e table 7) but the bullets,
as written, are OK. … Gans-Brangs,
Kathleen
(AstraZeneca)
Tables Table F-1 Page F-10Mean age in PLATO was 62 years. … Gans-Brangs,
Kathleen
(AstraZeneca)
Tables Table G-3, Page G-9: The table does not include the primary … Gans-Brangs,
Kathleen
(AstraZeneca)
Tables Table H-1, Page H-60: CKD subgroup- Reference stated … Gans-Brangs,
Kathleen
(AstraZeneca)
Tables Table H-1, Page H-62: Noninvasive management patients